Intimation/ Disclosure of events under Regulation 30 of Securities and Exchange Board of India( LODR) Regulation, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals Ltd has informed the stock exchange that its Board of Directors, at a meeting held on August 5, 2025, approved the appointment of Mrs. Bhumika Pradhan (DIN 10167275) as an Additional Non-Executive Independent Director of the company. The appointment is effective from August 5, 2025, and is subject to approval from shareholders. The appointment was recommended by the Nomination and Remuneration Committee and approved by the Audit Committee. Mrs. Pradhan has experience in management, leadership, strategic planning, and driving organizational growth. She is not related to any existing directors and has confirmed she is not debarred from holding a directorship by SEBI or any other authority.
This is a routine board strengthening move with no immediate material impact on the stock price. Adding an independent director may improve corporate governance standards, and shareholders will get to vote on confirming the appointment at a future general meeting.